Suppr超能文献

胃食管反流及其他因素在食管腺癌进展过程中的作用

The Role of Gastroesophageal Reflux and Other Factors during Progression to Esophageal Adenocarcinoma.

作者信息

Hazelton William D, Curtius Kit, Inadomi John M, Vaughan Thomas L, Meza Rafael, Rubenstein Joel H, Hur Chin, Luebeck E Georg

机构信息

Program in Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Department of Applied Mathematics, University of Washington, Seattle, Washington.

出版信息

Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1012-23. doi: 10.1158/1055-9965.EPI-15-0323-T. Epub 2015 Apr 30.

Abstract

BACKGROUND

U.S. esophageal adenocarcinoma (EAC) incidence increased over 5-fold between 1975 and 2009. Symptomatic gastroesophageal reflux disease (sGERD) elevates the risk for EAC. However, a simple calculation suggests that changes in sGERD prevalence can explain at most approximately 16% of this trend. Importantly, a mechanistic understanding of the influence of sGERD and other factors (OF) on EAC is lacking.

METHODS

A multiscale model was developed to estimate temporal trends for sGERD and OF, and their mechanistic role during carcinogenesis. Model calibration was to Surveillance, Epidemiology, and End Results (SEER) incidence and age-dependent sGERD data using maximum likelihood and Markov chain Monte Carlo (MCMC) methods.

RESULTS

Among men, 77.8% [95% credibility interval (CI), 64.9%-85.6%] of the incidence trend is attributable to OF, 13.4% (95% CI, 11.4%-17.3%) to sGERD, and 8.8% (95% CI, 4.2%-13.7%) to sGERD-OF interactions. Among women, 32.6% (95% CI, 27.0%-39.9%) of the trend is attributable to OF, 13.6% (95% CI, 12.5%-15.9%) to sGERD, and 47.4% (95% CI, 30.7%-64.6%) to interactions. The predicted trends were compared with historical trends for obesity, smoking, and proton pump inhibitor use. Interestingly, predicted OF cohort trends correlated most highly with median body mass index (BMI) at age 50 (r = 0.988 for men; r = 0.998 for women).

CONCLUSIONS

sGERD and OF mechanistically increase premalignant cell promotion, which increases EAC risk exponentially with exposure duration.

IMPACT

Surveillance should target individuals with long-duration sGERD and OF exposures.

摘要

背景

1975年至2009年间,美国食管腺癌(EAC)发病率增长了5倍多。症状性胃食管反流病(sGERD)会增加患EAC的风险。然而,简单计算表明,sGERD患病率的变化最多只能解释这一趋势的约16%。重要的是,目前尚缺乏对sGERD和其他因素(OF)对EAC影响的机制理解。

方法

开发了一个多尺度模型来估计sGERD和OF的时间趋势,以及它们在致癌过程中的机制作用。使用最大似然法和马尔可夫链蒙特卡罗(MCMC)方法,将模型校准到监测、流行病学和最终结果(SEER)发病率以及年龄相关的sGERD数据。

结果

在男性中,77.8%[95%可信区间(CI),64.9%-85.6%]的发病率趋势归因于OF,13.4%(95%CI,11.4%-17.3%)归因于sGERD,8.8%(95%CI,4.2%-13.7%)归因于sGERD与OF的相互作用。在女性中,32.6%(95%CI,27.0%-39.9%)的趋势归因于OF,13.6%(95%CI,12.5%-15.9%)归因于sGERD,47.4%(95%CI,30.7%-64.6%)归因于相互作用。将预测趋势与肥胖、吸烟和质子泵抑制剂使用的历史趋势进行了比较。有趣的是,预测的OF队列趋势与50岁时的中位体重指数(BMI)相关性最高(男性r = 0.988;女性r = 0.998)。

结论

sGERD和OF在机制上会增加癌前细胞的增殖,随着暴露时间的延长,EAC风险呈指数级增加。

影响

监测应针对长期暴露于sGERD和OF的个体。

相似文献

1
The Role of Gastroesophageal Reflux and Other Factors during Progression to Esophageal Adenocarcinoma.
Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1012-23. doi: 10.1158/1055-9965.EPI-15-0323-T. Epub 2015 Apr 30.
2
Gastroesophageal reflux does not alter effects of body mass index on risk of esophageal adenocarcinoma.
Clin Gastroenterol Hepatol. 2014 Jan;12(1):45-51. doi: 10.1016/j.cgh.2013.07.027. Epub 2013 Aug 3.
4
Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies.
Am J Gastroenterol. 2011 Feb;106(2):254-60. doi: 10.1038/ajg.2010.470. Epub 2010 Dec 7.
5
Controversies surrounding body mass, reflux, and risk of oesophageal adenocarcinoma.
Lancet Oncol. 2006 Apr;7(4):347-9. doi: 10.1016/S1470-2045(06)70660-X.
7
Erosive reflux disease increases risk for esophageal adenocarcinoma, compared with nonerosive reflux.
Clin Gastroenterol Hepatol. 2012 May;10(5):475-80.e1. doi: 10.1016/j.cgh.2011.12.038. Epub 2012 Jan 13.
8
Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction.
Am J Epidemiol. 2011 Sep 1;174(5):582-90. doi: 10.1093/aje/kwr117. Epub 2011 Jun 30.

引用本文的文献

1
A Reflux Linked GATA Factor Fulcrum Dictates Lineage Commitment Through GPRC5B During the Esophageal Dysplastic Transition.
Cell Mol Gastroenterol Hepatol. 2025 Jun 7;19(10):101552. doi: 10.1016/j.jcmgh.2025.101552.
2
Bibliometric and visual analysis of esophagogastric junction cancer research from 2002 to 2021.
Medicine (Baltimore). 2024 May 17;103(20):e38100. doi: 10.1097/MD.0000000000038100.
3
Molecular Biology and Clinical Management of Esophageal Adenocarcinoma.
Cancers (Basel). 2023 Nov 14;15(22):5410. doi: 10.3390/cancers15225410.
6
The Role of Microbiota in the Pathogenesis of Esophageal Adenocarcinoma.
Biology (Basel). 2021 Jul 22;10(8):697. doi: 10.3390/biology10080697.
7
Modeling historic incidence trends implies early field cancerization in esophageal squamous cell carcinoma.
PLoS Comput Biol. 2021 May 3;17(5):e1008961. doi: 10.1371/journal.pcbi.1008961. eCollection 2021 May.
8
Global burden and epidemiology of Barrett oesophagus and oesophageal cancer.
Nat Rev Gastroenterol Hepatol. 2021 Jun;18(6):432-443. doi: 10.1038/s41575-021-00419-3. Epub 2021 Feb 18.
9
The Esophageal Adenocarcinoma Epidemic Has Reached Hungary: A Multicenter, Cross-Sectional Study.
Front Oncol. 2020 Dec 23;10:541794. doi: 10.3389/fonc.2020.541794. eCollection 2020.
10
Optimal Timing for Cancer Screening and Adaptive Surveillance Using Mathematical Modeling.
Cancer Res. 2021 Feb 15;81(4):1123-1134. doi: 10.1158/0008-5472.CAN-20-0335. Epub 2020 Dec 8.

本文引用的文献

1
Microbiome in reflux disorders and esophageal adenocarcinoma.
Cancer J. 2014 May-Jun;20(3):207-10. doi: 10.1097/PPO.0000000000000044.
2
Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling.
Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):997-1006. doi: 10.1158/1055-9965.EPI-13-1233. Epub 2014 Apr 1.
4
What is behind the remarkable increase in esophageal adenocarcinoma?
Am J Gastroenterol. 2014 Mar;109(3):345-7. doi: 10.1038/ajg.2014.35.
5
Patterns of birth cohort-specific smoking histories, 1965-2009.
Am J Prev Med. 2014 Feb;46(2):e31-7. doi: 10.1016/j.amepre.2013.10.022.
6
Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux.
J Natl Cancer Inst. 2013 Nov 20;105(22):1711-8. doi: 10.1093/jnci/djt303. Epub 2013 Oct 29.
7
Gastro-esophageal reflux disease and obesity, where is the link?
World J Gastroenterol. 2013 Oct 21;19(39):6536-9. doi: 10.3748/wjg.v19.i39.6536.
9
Age at onset of GERD symptoms predicts risk of Barrett's esophagus.
Am J Gastroenterol. 2013 Jun;108(6):915-22. doi: 10.1038/ajg.2013.72. Epub 2013 Apr 9.
10
Proton pump inhibitor use in the U.S. ambulatory setting, 2002-2009.
PLoS One. 2013;8(2):e56060. doi: 10.1371/journal.pone.0056060. Epub 2013 Feb 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验